We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Quince Therapeutics Inc | NASDAQ:QNCX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.0022 | -0.25% | 0.8748 | 103,346 | 21:16:08 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 0.852 | 0.9147 | 0.914899 | 0.82 | 0.84 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | -31.39M | -0.7321 | -1.16 | 36.44M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 21:16:08 | formt | 200 | 0.8748 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 28/9/2023 | 21:53 | DJN | Quince Therapeutics to Advance Study of EryDex as FDA Lifts Application.. |
Quince Therapeutics (QNCX) Share Charts1 Year Quince Therapeutics Chart |
|
1 Month Quince Therapeutics Chart |
Intraday Quince Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
